NCT00593567COMPLETEDanonymous

A Study to Investigate the Safety and Efficacy of a Topical Gentamicin-Collagen Sponge Compared to Levofloxacin in Diabetic Patients With a Mild Infection of a Lower Extremity Skin Ulcer

Sponsor

Source record

Innocoll

Phase

Source record

PHASE2

Modality

AI-normalized

small molecule

Target

AI-normalized

gentamicin-collagen sponge, Levofloxacin

Indication / condition

AI-normalized

Diabetic Foot Ulcer

Intervention

Source record

gentamicin-collagen sponge, Levofloxacin

Source & freshness

Source record

NCT ID

NCT00593567

Original source

ClinicalTrials.gov

Source last updated

May 31, 2022

Ingested at

Jun 08, 2026

Internal sync

Jun 08, 2026

Model version

trialsignal-ai-v1

Normalized confidence

96%

Validation status

validated

Open original registry record

View original source fields

NCT ID

NCT00593567

Title

A Study to Investigate the Safety and Efficacy of a Topical Gentamicin-Collagen Sponge Compared to Levofloxacin in Diabetic Patients With a Mild Infection of a Lower Extremity Skin Ulcer

Sponsor

Innocoll

Status

COMPLETED

Phase

PHASE2

Condition raw

Diabetic Foot Ulcer

Condition normalized

Diabetic Foot Ulcer

Modality raw

small molecule

Modality normalized

small molecule

Target raw

gentamicin-collagen sponge, Levofloxacin

Target normalized

gentamicin-collagen sponge, Levofloxacin

Interventions

gentamicin-collagen sponge, Levofloxacin

Public preview

Source record

The purpose of this study is to determine whether the gentamicin-collagen sponge when combined with standard of daily wound care is safe and effective in treating mildly infected skin ulcers compared to treatment with an oral antibiotic (levofloxacin) and standard daily wound care.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections

Patent/IP landscape with verified records when available

Board-ready PDF export with source provenance

Save to folders and synthesize multiple assets in premium workspace

Create account

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

A Study to Investigate the Safety and Efficacy of a Topical Gentamicin-Collagen Sponge Compared to Levofloxacin in Diabetic Patients With a Mild Infection of a Lower Extremity Skin Ulcer

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 13, 2026

NCT ID

NCT00593567

Status

COMPLETED

Phase

PHASE2

Sponsor

Innocoll

Executive brief

Investment-Ready Snapshot

Source & freshness

Provenance

SourceClinicalTrials.gov

Source updatedMay 31, 2022

Internal syncJun 08, 2026

Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT00593567

Indication

Diabetic Foot Ulcer

Modality

small molecule

Target

gentamicin-collagen sponge, Levofloxacin

Intervention

gentamicin-collagen sponge, Levofloxacin

Source record

Protocol Description

Detailed source ingestion pending.

Source record

Outcome Measures

Detailed source ingestion pending.

Source record

Eligibility

Detailed source ingestion pending.

AI analysis

Known Results And Readout Context

Detailed source ingestion pending.

IP intelligence

Patent And IP Landscape

Detailed source ingestion pending.

Source record

Contacts

Detailed source ingestion pending.